Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GAPVD1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NABP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
N4BP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
EGLN1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC31A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FBXL20 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PLXDC2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC11A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MOB1A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DNAJC21 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
APPBP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SSR1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on